ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Niraparib Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-33Q9415
Home | Market Reports | Health| Pharmacy
Global Niraparib Market Insights and Forecast to 2028
BUY CHAPTERS

Global Niraparib Market Research Report 2025

Code: QYRE-Auto-33Q9415
Report
September 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Tesaro
Everest Pharmaceuticals Limited

Niraparib Market

The global market for Niraparib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Niraparib is a medication that is used to treat some types of cancer, such as ovarian, fallopian tube, or primary peritoneal cancer. It belongs to a class of drugs called PARP inhibitors, which block an enzyme that helps repair damaged DNA in cancer cells. By preventing DNA repair, niraparib can cause cancer cells to die or stop growing. Niraparib is taken by mouth as a capsule, usually once a day.
The future market trends of niraparib are expected to be positive, as the demand for this product is driven by the increasing prevalence of cancer and the need for effective and personalized treatment options. Niraparib has shown promising results in improving the survival and quality of life of patients with different types of cancer, especially those with BRCA mutations or homologous recombination deficiency (HRD). Niraparib is also being investigated for other indications, such as prostate, breast, and pancreatic cancer, as well as in combination with other therapies, such as immunotherapy or chemotherapy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Niraparib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Niraparib.
The Niraparib market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Niraparib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Niraparib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Niraparib Market Report

Report Metric Details
Report Name Niraparib Market
Segment by Type
  • 100mg*30 Capsules
  • 100mg*60 Capsules
  • 100mg*90 Capsules
Segment by Application
  • Recurrent Epithelial Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company TESARO, Everest Pharmaceuticals Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Niraparib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Niraparib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Niraparib Market report?

Ans: The main players in the Niraparib Market are TESARO, Everest Pharmaceuticals Limited

What are the Application segmentation covered in the Niraparib Market report?

Ans: The Applications covered in the Niraparib Market report are Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Others

What are the Type segmentation covered in the Niraparib Market report?

Ans: The Types covered in the Niraparib Market report are 100mg*30 Capsules, 100mg*60 Capsules, 100mg*90 Capsules

1 Niraparib Market Overview
1.1 Product Definition
1.2 Niraparib by Type
1.2.1 Global Niraparib Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg*30 Capsules
1.2.3 100mg*60 Capsules
1.2.4 100mg*90 Capsules
1.3 Niraparib by Application
1.3.1 Global Niraparib Market Value by Application (2024 VS 2031)
1.3.2 Recurrent Epithelial Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Primary Peritoneal Cancer
1.3.5 Others
1.4 Global Niraparib Market Size Estimates and Forecasts
1.4.1 Global Niraparib Revenue 2020-2031
1.4.2 Global Niraparib Sales 2020-2031
1.4.3 Global Niraparib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Niraparib Market Competition by Manufacturers
2.1 Global Niraparib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Niraparib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Niraparib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Niraparib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Niraparib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Niraparib, Product Type & Application
2.7 Global Key Manufacturers of Niraparib, Date of Enter into This Industry
2.8 Global Niraparib Market Competitive Situation and Trends
2.8.1 Global Niraparib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Niraparib Players Market Share by Revenue
2.8.3 Global Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Niraparib Market Scenario by Region
3.1 Global Niraparib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Niraparib Sales by Region: 2020-2031
3.2.1 Global Niraparib Sales by Region: 2020-2025
3.2.2 Global Niraparib Sales by Region: 2026-2031
3.3 Global Niraparib Revenue by Region: 2020-2031
3.3.1 Global Niraparib Revenue by Region: 2020-2025
3.3.2 Global Niraparib Revenue by Region: 2026-2031
3.4 North America Niraparib Market Facts & Figures by Country
3.4.1 North America Niraparib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Niraparib Sales by Country (2020-2031)
3.4.3 North America Niraparib Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Niraparib Market Facts & Figures by Country
3.5.1 Europe Niraparib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Niraparib Sales by Country (2020-2031)
3.5.3 Europe Niraparib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Niraparib Market Facts & Figures by Region
3.6.1 Asia Pacific Niraparib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Niraparib Sales by Region (2020-2031)
3.6.3 Asia Pacific Niraparib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Niraparib Market Facts & Figures by Country
3.7.1 Latin America Niraparib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Niraparib Sales by Country (2020-2031)
3.7.3 Latin America Niraparib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Niraparib Market Facts & Figures by Country
3.8.1 Middle East and Africa Niraparib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Niraparib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Niraparib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Niraparib Sales by Type (2020-2031)
4.1.1 Global Niraparib Sales by Type (2020-2025)
4.1.2 Global Niraparib Sales by Type (2026-2031)
4.1.3 Global Niraparib Sales Market Share by Type (2020-2031)
4.2 Global Niraparib Revenue by Type (2020-2031)
4.2.1 Global Niraparib Revenue by Type (2020-2025)
4.2.2 Global Niraparib Revenue by Type (2026-2031)
4.2.3 Global Niraparib Revenue Market Share by Type (2020-2031)
4.3 Global Niraparib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Niraparib Sales by Application (2020-2031)
5.1.1 Global Niraparib Sales by Application (2020-2025)
5.1.2 Global Niraparib Sales by Application (2026-2031)
5.1.3 Global Niraparib Sales Market Share by Application (2020-2031)
5.2 Global Niraparib Revenue by Application (2020-2031)
5.2.1 Global Niraparib Revenue by Application (2020-2025)
5.2.2 Global Niraparib Revenue by Application (2026-2031)
5.2.3 Global Niraparib Revenue Market Share by Application (2020-2031)
5.3 Global Niraparib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 TESARO
6.1.1 TESARO Company Information
6.1.2 TESARO Description and Business Overview
6.1.3 TESARO Niraparib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 TESARO Niraparib Product Portfolio
6.1.5 TESARO Recent Developments/Updates
6.2 Everest Pharmaceuticals Limited
6.2.1 Everest Pharmaceuticals Limited Company Information
6.2.2 Everest Pharmaceuticals Limited Description and Business Overview
6.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Everest Pharmaceuticals Limited Niraparib Product Portfolio
6.2.5 Everest Pharmaceuticals Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Niraparib Industry Chain Analysis
7.2 Niraparib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Niraparib Production Mode & Process Analysis
7.4 Niraparib Sales and Marketing
7.4.1 Niraparib Sales Channels
7.4.2 Niraparib Distributors
7.5 Niraparib Customer Analysis
8 Niraparib Market Dynamics
8.1 Niraparib Industry Trends
8.2 Niraparib Market Drivers
8.3 Niraparib Market Challenges
8.4 Niraparib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Tesaro
Everest Pharmaceuticals Limited
List of Tables
 Table 1. Global Niraparib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Niraparib Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Niraparib Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Niraparib Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Niraparib Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Niraparib Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Niraparib Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Niraparib Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Niraparib, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Niraparib, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Niraparib, Product Type & Application
 Table 12. Global Key Manufacturers of Niraparib, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Niraparib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Niraparib as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Niraparib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Niraparib Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Niraparib Sales Market Share by Region (2020-2025)
 Table 19. Global Niraparib Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Niraparib Sales Market Share by Region (2026-2031)
 Table 21. Global Niraparib Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Niraparib Revenue Market Share by Region (2020-2025)
 Table 23. Global Niraparib Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Niraparib Revenue Market Share by Region (2026-2031)
 Table 25. North America Niraparib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Niraparib Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Niraparib Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Niraparib Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Niraparib Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Niraparib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Niraparib Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Niraparib Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Niraparib Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Niraparib Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Niraparib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Niraparib Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Niraparib Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Niraparib Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Niraparib Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Niraparib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Niraparib Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Niraparib Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Niraparib Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Niraparib Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Niraparib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Niraparib Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Niraparib Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Niraparib Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Niraparib Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Niraparib Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Niraparib Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Niraparib Sales Market Share by Type (2020-2025)
 Table 53. Global Niraparib Sales Market Share by Type (2026-2031)
 Table 54. Global Niraparib Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Niraparib Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Niraparib Revenue Market Share by Type (2020-2025)
 Table 57. Global Niraparib Revenue Market Share by Type (2026-2031)
 Table 58. Global Niraparib Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Niraparib Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Niraparib Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Niraparib Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Niraparib Sales Market Share by Application (2020-2025)
 Table 63. Global Niraparib Sales Market Share by Application (2026-2031)
 Table 64. Global Niraparib Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Niraparib Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Niraparib Revenue Market Share by Application (2020-2025)
 Table 67. Global Niraparib Revenue Market Share by Application (2026-2031)
 Table 68. Global Niraparib Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Niraparib Price (USD/Pcs) by Application (2026-2031)
 Table 70. TESARO Company Information
 Table 71. TESARO Description and Business Overview
 Table 72. TESARO Niraparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. TESARO Niraparib Product
 Table 74. TESARO Recent Developments/Updates
 Table 75. Everest Pharmaceuticals Limited Company Information
 Table 76. Everest Pharmaceuticals Limited Description and Business Overview
 Table 77. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Everest Pharmaceuticals Limited Niraparib Product
 Table 79. Everest Pharmaceuticals Limited Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Niraparib Distributors List
 Table 83. Niraparib Customers List
 Table 84. Niraparib Market Trends
 Table 85. Niraparib Market Drivers
 Table 86. Niraparib Market Challenges
 Table 87. Niraparib Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Niraparib
 Figure 2. Global Niraparib Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Niraparib Market Share by Type: 2024 & 2031
 Figure 4. 100mg*30 Capsules Product Picture
 Figure 5. 100mg*60 Capsules Product Picture
 Figure 6. 100mg*90 Capsules Product Picture
 Figure 7. Global Niraparib Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Niraparib Market Share by Application: 2024 & 2031
 Figure 9. Recurrent Epithelial Ovarian Cancer
 Figure 10. Fallopian Tube Cancer
 Figure 11. Primary Peritoneal Cancer
 Figure 12. Others
 Figure 13. Global Niraparib Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Niraparib Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Niraparib Sales (2020-2031) & (K Pcs)
 Figure 16. Global Niraparib Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Niraparib Report Years Considered
 Figure 18. Niraparib Sales Share by Manufacturers in 2024
 Figure 19. Global Niraparib Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Niraparib Players: Market Share by Revenue in Niraparib in 2024
 Figure 21. Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Niraparib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Niraparib Sales Market Share by Country (2020-2031)
 Figure 24. North America Niraparib Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Niraparib Sales Market Share by Country (2020-2031)
 Figure 28. Europe Niraparib Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Niraparib Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Niraparib Revenue Market Share by Region (2020-2031)
 Figure 36. China Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Niraparib Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Niraparib Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Niraparib Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Niraparib Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Niraparib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Niraparib by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Niraparib by Type (2020-2031)
 Figure 58. Global Niraparib Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Niraparib by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Niraparib by Application (2020-2031)
 Figure 61. Global Niraparib Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Niraparib Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Niraparib Tosylate Market Research Report 2025
Global Olaparib Market Research Report 2024
Global Nimorazole Market Research Report 2025
Global Pazopanib Market Research Report 2024
Global Talazoparib Market Research Report 2024
Global Nivolumab Market Research Report 2024
Global Regorafenib Market Research Report 2024
Global Urapidil Market Research Report 2024
Global Neratinib Market Research Report 2024
Global Nitrendipine Market Research Report 2025
Global Flurbiprofen Market Research Report 2024
Global Rifabutin Market Research Report 2024
Global Topiramate Market Research Report 2024
Global Metiram Market Research Report 2025
Global Enalapril API Market Research Report 2024
Global Rilpivirine Market Research Report 2024
Global Tenapanor Market Research Report 2024
Global Apatinib Market Research Report 2024
Global Ruxolitinib Market Research Report 2024
Global Ramucirumab Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions